Navigation Links
Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
Date:2/20/2008

ation, the basis of Addrenex's drug development efforts.

"We credit our rapid success in developing viable drugs and building partnerships to our nimble, fast-paced business model and outside-the-box thinking," Khayrallah said. "We stay sharply focused on the major milestones that must be accomplished, and we don't allow perceived impediments to hamper our progress."

Addrenex's goal is to develop a diverse pipeline of products aimed at regulating the adrenergic system, a vast and varied regulator of multiple bodily processes. The alpha-2 adrenergic receptors in particular have been implicated in a wide variety of medical conditions, including hypertension, ADHD, menopausal flushing, migraine, sleep disturbances, aggression, pain and addiction.

Few drugs on the market are known to target the alpha-2 adrenergic receptors; hence, Addrenex is seeking to fill a void in this pharmaceutical niche, Khayrallah said.

About Addrenex Pharmaceuticals, Inc.

Addrenex Pharmaceuticals is a focused, specialty pharmaceutical company that develops and commercializes drugs to treat adrenergic dysregulation. Addrenex Pharmaceuticals is based in Durham, North Carolina, on the edge of Research Triangle Park. The company was formed in 2006 by a practicing physician and a drug development expert with the mission to explore the impact that neurotransmitter regulation has on a variety of diseases and disorders. Addrenex identified adrenergic regulation as its initial research focus. Adrenergic dysregulation is implicated in medical conditions such as hypertension, ADHD, migraine, and post-menopausal symptoms. Addrenex will use the knowledge and experience gained from developing CloniBID and Clonicel as the foundation for additional discovery and development in the area of adrenergic regulation.


'/>"/>
SOURCE Addrenex Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split
2. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
3. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, February 27, 2008
4. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
8. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Canada (PRWEB) January 15, 2014 ... regulatory perspectives on nonclinical and clinical safety assessment ... countries to guide a path for biosimilar drug ... the demonstration of biosimilarity with regards to quality, ... specific aspects of biosimilar drug development and registration, ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... of these latent viruses is the Epstein Barr Virus ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease ... theory, a study found that RA patients have high ... , What is Microcompetition? , Dr. Hanan Polansky discovered ...
(Date:1/15/2014)... ON (PRWEB) January 15, 2014 ... Therapy, an experimental new therapy for the treatment of ... tailor-made for their unique tinnitus frequency, and over a ... , AudioNotch has previously provided Notched Sound Therapy in ... AudioNotch is pleased to announce to release of a ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine ... cells grown under simulated embryonic conditions, today announced ... agreement with Suneva Medical, Inc. for physician-dispensed aesthetic ... (CCM). , This agreement is an ... Suneva Medical, through which Suneva has exclusively licensed ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Based on the clinical success,of its facet replacement ... has expanded its executive management team and established,its ... Massachusetts,allows us to consolidate our operations in one ... gives us access to a wealth of,talent in ...
... Winners of 2008 R&D 100 Awards Now Online, ... the,finalists for the 8th Annual Innovator of the Year ... individuals who exemplify the,ideals of R&D in academia, industry, ... facilitated online with ten finalists,-- five scientists and five ...
... pleased to announce that Dr. Francis Stoessel, a leading ... will be the Keynote Speaker in the Process Safety ... ... Columbia, MD (PRWEB) October ...
Cached Biology Technology:Facet Solutions Establishes Corporate Headquarters and Expands Executive Team 22008 R&D Innovator of the Year & Scientist of the Year Finalists Announced 2
(Date:4/15/2014)... nanoparticle form could help reduce side effects by targeting ... scientists have developed nanoparticles that deliver one or two ... design particles that can carry any more than that ... devised a new way to build such nanoparticles, making ... drugs. In a paper published in the Journal ...
(Date:4/15/2014)... become clear that the genetic code is far ... the well-known building blocks adenine, cytosine, guanine, and ... Scientists now assume that the newly discovered nucleic ... information that extends and complements the genetic code. ... extend the standard alphabet," explained Professor Mark Helm ...
(Date:4/15/2014)... Rosemont, IL (April 15, 2014) New research ... Journal of the American College of Nutrition shows ... exercise or as part of a weight-loss or weight-maintenance ... body composition. , The meta-analysis included 14 randomized ... When researchers analyzed those weight loss studies that used ...
Breaking Biology News(10 mins):Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3German Research Foundation approves new priority program in the life sciences 2New meta-analysis builds on the power of whey protein for improved body composition 2New meta-analysis builds on the power of whey protein for improved body composition 3
... Terrace, Ill., March 8, 2010 Americans recognize things need ... Sam,s efforts to overhaul what is included in their food ... are individually responsible for making the right food choices to ... be successful, according to a new survey by FoodMinds. ...
... the fractious debate on the existence of God and ... the discussion. Taking a perspective rooted in evolutionary biology ... (Prometheus Books, $25) renowned anthropologist Lionel Tiger and pioneering ... is its purpose? How did it arise? What is ...
... problems have to be fed intravenously. There moreover, exist systems ... Mr Iaki Irastorza, paediatrician at the Cruces hospital in Bilbao, ... children were treated at the Great Ormond Street Children,s Hospital ... highly novel PhD thesis at the University of the Basque ...
Cached Biology News:Americans want Uncle Sam's help putting healthy foods on their dinner table 2Which came first: Religion or the brain? 2First time research on long-term consequences of intravenous nutrition on children's health 2First time research on long-term consequences of intravenous nutrition on children's health 3
... analysis kit for 10 chips provides the ... analysis with the Experion automated electrophoresis system. ... 3 x 520 microliters Pro260 gel, 45 ... (10-260 kD), 400 microliters Pro260 sample buffer, ...
... original Gene Pulser apparatus and accessory modules the ... in the Gene Pulser II system, which features ... Gene Pulser II system has the dual advantages ... range of settings to target specific cell types ...
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as...
... Pro260 reagents and supplies, for 10 ... sufficient to perform protein analysis with ... electrophoresis system. Supplied are 3 x ... Pro260 stain, 60 microliters Pro260 ladder ...
Biology Products: